GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) » Definitions » Total Assets

Guangdong Zhongsheng Pharmaceutical Co (SZSE:002317) Total Assets : ¥5,233 Mil (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Guangdong Zhongsheng Pharmaceutical Co Total Assets?

Guangdong Zhongsheng Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2025 was ¥5,233 Mil.

During the past 12 months, Guangdong Zhongsheng Pharmaceutical Co's average Total Assets Growth Rate was -15.30% per year. During the past 3 years, the average Total Assets Growth Rate was 1.80% per year. During the past 5 years, the average Total Assets Growth Rate was 0.90% per year. During the past 10 years, the average Total Assets Growth Rate was 4.10% per year.

During the past 13 years, Guangdong Zhongsheng Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 57.00%. The lowest was -7.10%. And the median was 16.05%.

Total Assets is connected with ROA %. Guangdong Zhongsheng Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2025 was 6.13%. Total Assets is also linked to Revenue through Asset Turnover. Guangdong Zhongsheng Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2025 was 0.12.


Guangdong Zhongsheng Pharmaceutical Co Total Assets Historical Data

The historical data trend for Guangdong Zhongsheng Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Zhongsheng Pharmaceutical Co Total Assets Chart

Guangdong Zhongsheng Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,784.00 4,901.98 5,775.28 6,458.52 5,553.49

Guangdong Zhongsheng Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,225.44 5,790.41 5,820.05 5,553.49 5,232.78

Guangdong Zhongsheng Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Guangdong Zhongsheng Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=4010.114+1543.379
=5,553

Guangdong Zhongsheng Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (Q: Mar. 2025 )+Total Liabilities (Q: Mar. 2025 )
=4094.013+1138.762
=5,233

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangdong Zhongsheng Pharmaceutical Co  (SZSE:002317) Total Assets Explanation

Total Assets is connected with ROA %.

Guangdong Zhongsheng Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2025 is

ROA %=Net Income (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=330.448/( (5553.493+5232.775)/ 2 )
=330.448/5393.134
=6.13 %

Note: The Net Income data used here is four times the quarterly (Mar. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Guangdong Zhongsheng Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2025 is

Asset Turnover
=Revenue (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=634.261/( (5553.493+5232.775)/ 2 )
=634.261/5393.134
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Guangdong Zhongsheng Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Guangdong Zhongsheng Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Zhongsheng Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Xihu Industrial Zone, Information Industry Park, Shilong Town, Guangdong Province, Dongguan, CHN, 523325
Guangdong Zhongsheng Pharmaceutical Co Ltd is engaged in the pharmaceutical business. It is involved in the research and development, production and sales of pharmaceuticals, the cultivation of medicinal materials, and the processing of medicinal herbs, chemical raw material synthesis, and pharmaceutical trade.
Executives
Chen Yong Hong Directors, executives
Zhao Xi Ping Executives
Zhou Xue Li Director
Zhang Yu Chong Secretary, Director
Yin Yuan Yuan Executives
Li Su Xian Supervisors
Long Chun Hua Directors, executives
Ding Chen Huan Supervisors
Li Tao Executives
Cao Jia Yue Supervisors
Zhang Shao Ri Director
Ye Hui Tang Director
Long Chao Feng Directors, executives
Sun Xian Peng Independent director
Huang Shi Bin Supervisors

Guangdong Zhongsheng Pharmaceutical Co Headlines

No Headlines